Raiffeisen Bank International AG Takes $377,000 Position in CVS Health Co. (NYSE:CVS)

Raiffeisen Bank International AG acquired a new stake in shares of CVS Health Co. (NYSE:CVS - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 8,580 shares of the pharmacy operator's stock, valued at approximately $377,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of CVS. Park Avenue Securities LLC grew its holdings in CVS Health by 5.8% during the 4th quarter. Park Avenue Securities LLC now owns 24,646 shares of the pharmacy operator's stock worth $1,106,000 after acquiring an additional 1,359 shares during the last quarter. Empirical Asset Management LLC lifted its holdings in shares of CVS Health by 816.4% during the fourth quarter. Empirical Asset Management LLC now owns 36,885 shares of the pharmacy operator's stock worth $1,656,000 after purchasing an additional 32,860 shares during the period. Avanza Fonder AB bought a new stake in shares of CVS Health in the fourth quarter worth $4,745,000. HB Wealth Management LLC increased its holdings in CVS Health by 12.7% in the fourth quarter. HB Wealth Management LLC now owns 20,029 shares of the pharmacy operator's stock valued at $899,000 after purchasing an additional 2,262 shares during the period. Finally, Clarius Group LLC raised its position in CVS Health by 41.0% during the 4th quarter. Clarius Group LLC now owns 5,116 shares of the pharmacy operator's stock worth $230,000 after purchasing an additional 1,487 shares during the last quarter. Institutional investors own 80.66% of the company's stock.

Insider Transactions at CVS Health

In other CVS Health news, SVP James David Clark sold 7,513 shares of the business's stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the sale, the senior vice president now directly owns 8,394 shares of the company's stock, valued at approximately $556,941.90. The trade was a 47.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.22% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have commented on CVS. Mizuho upped their price target on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Leerink Partners upgraded CVS Health from a "market perform" rating to an "outperform" rating and upped their target price for the company from $55.00 to $75.00 in a report on Thursday, February 13th. Truist Financial raised their price target on shares of CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a report on Monday, May 12th. Morgan Stanley reaffirmed an "overweight" rating on shares of CVS Health in a research note on Tuesday, April 15th. Finally, Royal Bank of Canada increased their price objective on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research report on Monday, May 5th. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, CVS Health has a consensus rating of "Moderate Buy" and an average target price of $74.94.

CVS Health Stock Down 2.5%

CVS Health stock traded down $1.62 during midday trading on Wednesday, reaching $62.13. The stock had a trading volume of 6,152,935 shares, compared to its average volume of 11,369,544. The company has a fifty day moving average price of $66.48 and a two-hundred day moving average price of $59.32. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $72.51. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $78.59 billion, a P/E ratio of 16.97, a PEG ratio of 0.98 and a beta of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The firm had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter in the previous year, the company posted $1.31 earnings per share. The company's quarterly revenue was up 7.0% on a year-over-year basis. As a group, equities analysts expect that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.28%. The ex-dividend date was Tuesday, April 22nd. CVS Health's dividend payout ratio is currently 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.